Effects of morning vs evening dosing on the pharmacokinetics and pharmacodynamics of sunitinib. Effect van ochtend- of avondinname van sunitinib op de medicijnspiegels in het bloed
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2016
At a glance
- Drugs Sunitinib (Primary)
- Indications Gastrointestinal stromal tumours; Pancreatic cancer; Renal cell carcinoma
- Focus Pharmacogenomic; Pharmacokinetics
- 30 Jul 2012 New source identified and integrated (Netherlands Trial Register; NTR3526).
- 30 Jul 2012 Additional lead trial centre identified as reported by Netherlands Trial Register.
- 30 Jul 2012 Planned End Date 1 Jul 2014 added as reported by Netherlands Trial Register.